Clinical trial
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat…
NCT00448097 · The Methodist Hospital Research Institute, Other · Terminated
Key facts
| NCT number | NCT00448097 |
|---|---|
| Title | Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy |
| Official title | A Randomized Study of Cetuximab or Cetuximab Plus Docetaxel Followed by Radical Prostatectomy for Patients With Adenocarcinoma of the Prostate |
| Lead sponsor | The Methodist Hospital Research Institute, Other |
| Collaborators | Bristol-Myers Squibb Industry Eli Lilly and Company |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Drug |
| Interventions | cetuximab, docetaxel |
| Enrollment | 7 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Mar 15, 2007 |
| Last update posted | Mar 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: